Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 10, 2010
Recent developments in pricing and reimbursement of medicines in Ireland
Michael Barry, Lesley Tilson
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 16, 2010
Recent developments in pharmacoeconomic evaluation in Ireland
Lesley Tilson, Michael Barry
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 16, 2010
Public drug expenditure in the Republic of Ireland
Michael Barry, Cara Usher, Lesley Tilson
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Pricing and reimbursement of drugs in Ireland
Michael Barry, Lesley Tilson, Máirín Ryan
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 25, 2005
The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland
Lesley Tilson, Kathleen Bennett, Michael Barry
Pharmacoeconomics
|
August 29, 2009
Estimating drug costs in economic evaluations in Ireland and the UK: an analysis of practice and research recommendations
Dyfrig A Hughes, Lesley Tilson, Michael Drummond
Pharmacoeconomics
|
October 7, 2009
A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting
Laura McCullagh, Lesley Tilson, Cathal Walsh, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 2, 2020
To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in Ireland
Helen O'Donnell, Felicity Lamrock, Lesley Tilson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 2, 2020
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland
Felicity Lamrock, Laura McCullagh, Lesley Tilson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
The high cost of medicines in Ireland. Is it time to change the pricing mechanism?
Lesley Tilson, Bernadette McGowan, Kathleen Bennett, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 10, 2010
Recent developments in pricing and reimbursement of medicines in Ireland
Michael Barry, Lesley Tilson
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 16, 2010
Recent developments in pharmacoeconomic evaluation in Ireland
Lesley Tilson, Michael Barry
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 16, 2010
Public drug expenditure in the Republic of Ireland
Michael Barry, Cara Usher, Lesley Tilson
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Pricing and reimbursement of drugs in Ireland
Michael Barry, Lesley Tilson, Máirín Ryan
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
June 25, 2005
The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland
Lesley Tilson, Kathleen Bennett, Michael Barry
Pharmacoeconomics
|
August 29, 2009
Estimating drug costs in economic evaluations in Ireland and the UK: an analysis of practice and research recommendations
Dyfrig A Hughes, Lesley Tilson, Michael Drummond
Pharmacoeconomics
|
October 7, 2009
A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting
Laura McCullagh, Lesley Tilson, Cathal Walsh, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 2, 2020
To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in Ireland
Helen O'Donnell, Felicity Lamrock, Lesley Tilson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
April 2, 2020
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland
Felicity Lamrock, Laura McCullagh, Lesley Tilson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
The high cost of medicines in Ireland. Is it time to change the pricing mechanism?
Lesley Tilson, Bernadette McGowan, Kathleen Bennett, et al.
Page
of 3